- CF patients initiating ivacaftor therapy experienced changes in cholesterol levels.
- BMI correlated with increased TC levels, suggesting a metabolic effect of modulator therapy.
- Variable lipid screening practices among CF providers were observed.
- Growing need for CF specialists to collaborate with primary care providers and cardiologists to manage cardiovascular risk.
- The study emphasized the evolving landscape of CF care as patients live longer and encounter new health challenges.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
